2017-03-21,Biotech Premarket Movers: Esperion, Minerva and BioCryst
2017-03-20,How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More
2017-03-20,Biotechs Remain the Best Place For Stock Picking
2017-03-20,Biotech Premarket Movers: CytomX, Aevi, Esperion
2017-03-20,Esperion Announces FDA Confirmation Regarding Regulatory Pathway To Approval For An LDL-C Lowering Indication For Bempedoic Acid
2017-03-17,AveXis, Esperion and Amgen Among Biotech Movers
2017-03-07,Esperion Announces Initiation Of Phase 2 Triplet Oral Therapy Study Of Bempedoic Acid/Ezetimibe/Atorvastatin
2017-03-06,Esperion Announces Oral Presentation On Genetic Validation Of ATP Citrate Lyase Inhibition At The American College Of Cardiology 66th Annual Scientific Session
2017-02-28,PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round
2017-02-28,Here's Why Buffett Is So Bullish About This Market: Cramer's 'Mad Money' Recap (Monday 2/27/17)
2017-02-22,First Week of April 21st Options Trading For Esperion Therapeutics
2017-02-22,Esperion Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter And Full Year 2016 Financial Results
2017-02-15,Esperion To Participate In Fireside Chat At RBC Capital Markets Global Healthcare Conference
2017-02-07,Esperion Therapeutics Reaches Analyst Target Price
2017-02-03,Premarket Biotech Movers: Portola, Esperion, Medicines
2017-01-25,Esperion Completes Enrollment Of Pivotal Phase 3 Long-Term Safety And Tolerability Study Of Bempedoic Acid In Patients With Hypercholesterolemia
2017-01-11,Notable Two Hundred Day Moving Average Cross - ESPR
2017-01-09,Esperion Announces Initiation Of Global Cardiovascular Outcomes Trial For Bempedoic Acid
2017-01-08,Esperion Announces Initiation Of Three Pivotal Phase 3 Studies For Bempedoic Acid
2017-01-06,Commit To Buy Esperion Therapeutics At $11, Earn 24.7% Annualized Using Options
2017-01-04,Esperion To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-12-19,Bullish Two Hundred Day Moving Average Cross - ESPR
2016-11-29,ESPR: Insiders vs. Shorts
2016-11-28,Esperion Therapeutics Announces Publication Of Definitive Paper On Bempedoic Acid Mechanism Of Action In Nature Communications
2016-11-09,Esperion Therapeutics To Present At The Stifel 2016 Healthcare Conference
2016-11-03,Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial Results
2016-11-01,Esperion Therapeutics To Present At The Credit Suisse 25th Annual Healthcare Conference
2016-10-13,Bempedoic Acid Global Phase 3 Clinical Program To Include Patients On Any Statin At Any Dose
2016-09-23,7 Unusual-Volume Stocks That Are About to Break Out
2016-08-31,ESPR: Insiders vs. Shorts
2016-08-04,Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Second Quarter 2016 Financial Results
2016-07-15,It's Time to Bring the Heat
2016-07-08,These 5 Stocks Are Breaking Out
2016-07-07,Commit To Purchase Esperion Therapeutics At $8, Earn 28.2% Annualized Using Options
2016-06-28,Esperion Falls on Regulatory Setback for Cholesterol-Lowering Pill
2016-06-28,Esperion Therapeutics Provides Clinical Development And Regulatory Update For Bempedoic Acid
2016-06-01,ESPR: Insiders vs. Shorts
2016-05-04,Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2016 Financial Results
2016-04-08,Commit To Buy Esperion Therapeutics At $13, Earn 23.5% Annualized Using Options
2016-03-11,INVESTOR DEADLINE: Law Office Of Brodsky & Smith, LLC Announces Investigation Of Esperion Therapeutics, Inc.
2016-03-08,Esperion Therapeutics To Present At The Barclays Global Healthcare Conference
2016-03-08,Scott + Scott, LLP Notifies Investors That Monday, March 14, 2016 Is Last Day To File Lead Plaintiff Papers In Esperion Therapeutics (ESPR) Securities Case
2016-03-08,INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Esperion Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 14, 2016 - ESPR
2016-03-07,Scott + Scott, LLP Notifies Investors Of Monday, March 14, 2016 Deadline In Esperion Therapeutics (ESPR) Securities Case
2016-03-04,SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of Esperion Therapeutics, Inc.
2016-03-03,Scott + Scott, LLP Notifies Investors Of Monday, March 14, 2016 Deadline In Esperion Therapeutics (ESPR) Securities Case
2016-03-02,ESPR: Insiders vs. Shorts
2016-03-02,Scott + Scott, LLP Reminds Investors Of Monday, March 14, 2016 Deadline To File Lead Plaintiff Papers In Esperion Therapeutics (ESPR) Securities Case
2016-02-26,The Former Attorney General Of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors Of Lead Plaintiff Deadline In Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR
2016-02-26,INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Esperion Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 14, 2016
2016-02-25,Esperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter And Full Year 2015 Financial Results
2016-02-23,ESPERION INVESTORS NOTICE: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Esperion Therapeutics, Inc.
2016-02-23,SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving Esperion Therapeutics, Inc. And A Lead Plaintiff Deadline Of March 14, 2016
2016-02-22,SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of Esperion Therapeutics, Inc. - ESPR
2016-02-19,INVESTOR ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving Esperion Therapeutics, Inc. And A Lead Plaintiff Deadline Of March 14, 2016 - ESPR
2016-02-16,Esperion Therapeutics To Present At The 2016 RBC Capital Markets Global Healthcare Conference
2016-02-16,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Esperion Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 14, 2016
2016-02-14,UPCOMING DEADLINE ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Esperion Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2016-02-10,SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving Esperion Therapeutics, Inc. And A Lead Plaintiff Deadline Of March 14, 2016
2016-02-09,ESPERION INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Esperion Therapeutics, Inc.
2016-02-09,SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Esperion Therapeutics, Inc. To Contact The Firm Before Upcoming Lead Plaintiff Deadline
2016-02-05,5 Stocks Ready for Breakouts
2016-02-02,Investor Alert: Peiffer Rosca Wolf Law Firm Announces Filing Of A Shareholder Class Action Against Esperion Therapeutics, Inc. ("Esperion" Or "Company") (NASDAQ: ESPR) In The U.S. District Court For The Eastern District Of Michigan.
2016-02-01,Investor Alert: Peiffer Rosca Wolf Law Firm Announces Filing Of A Shareholder Class Action Against Esperion Therapeutics, Inc. ("Esperion" Or "Company") (NASDAQ: ESPR) In The U.S. District Court For The Eastern District Of Michigan
2016-02-01,ESPR INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Esperion Therapeutics, Inc.
2016-01-25,INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Esperion Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2016-01-22,Investor Alert: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. And Encourages Investors To Contact The Firm Before The Deadline
2016-01-22,STOCK ALERT: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors Of Important Deadline In Class Action
2016-01-19,Esperion Therapeutics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors
2016-01-16,IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. And Encourages Investors With Losses To Contact The Firm
2016-01-15,The Former Attorney General Of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors Of Lead Plaintiff Deadline In Class Action Lawsuit Against Esperion Therapeutics, Inc.
2016-01-14,Shareholder Class Action Filed Against Esperion Therapeutics, Inc. - ESPR
2016-01-14,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Esperion Therapeutics, Inc. - ESPR
2016-01-14,Law Offices Of Marc S. Henzel Announces Investigation Of Companies For Violations Of The Federal Securities Laws
2016-01-13,Lifshitz & Miller Law Firm Announces Investigation Of Anavex Life Sciences Corp., Esperion Therapeutics, Inc., Fitbit Inc., KLX, Inc., Natural Health Trends Corp., Nimble Storage, Inc., And Straight Path Communications Inc.
2016-01-13,Kirby McInerney LLP Advises Esperion Therapeutics, Inc. Investors Of Potential Claims
2016-01-13,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Esperion Therapeutics, Inc. (ESPR) And Lead Plaintiff Deadline March 14, 2016
2016-01-13,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR
2016-01-13,Esperion Therapeutics Announces Initiation Of Phase 3 Clinical Program With Long-Term Safety And Tolerability Study
2016-01-12,Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Esperion Therapeutics, Inc.
2016-01-12,Esperion Therapeutics Announces Initiation Of Phase 2 Clinical Study Of Bempedoic Acid In Patients Treated With High-Dose Statin Therapy
2016-01-08,Commit To Purchase Esperion Therapeutics At $12, Earn 21.7% Annualized Using Options
2016-01-06,Esperion Therapeutics is Now Oversold (ESPR)
2016-01-06,Esperion Therapeutics To Present At 34th Annual J.P. Morgan Healthcare Conference
2016-01-06,Investor Alert: Investigation Of Esperion Therapeutics Announced By Holzer & Holzer, LLC
2015-11-13,'Mad Money' Lightning Round: Forget Revance, I Want Allergan
2015-11-12,Jim Cramer's 'Mad Money' Recap: There's Negative, and There's Too Negative
2015-10-12,Why Esperion Therapeutics (ESPR) Stock is Climbing Today
2015-10-12,Lilly Sinks as Cholesterol-Lowering Pill Trial Shut Down
2015-10-05,Relative Strength Alert For Esperion Therapeutics
2015-10-02,Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters
2015-09-28,Interesting ESPR Put And Call Options For November 20th
2015-09-16,Amgen Adds Cholesterol-Lowering Pill to Pipeline With New Acquisition
2015-08-14,Commit To Buy Esperion Therapeutics At $55, Earn 35.3% Annualized Using Options
2015-08-14,Esperion Therapeutics Stock Sees Short Interest Move 19.6% Lower
2015-08-10,Scott Braunstein Joins Aisling Capital As Operating Partner
2015-07-30,This Market Lift Should Linger
2015-06-10,Jim Cramer -- Investors Should Be Patient on Regeneron Cholesterol Drug
2015-06-03,Where the Money Was Made the Last 5 Years
2015-04-01,The Top-Performing Biotech Stock During a Sizzling First Quarter
2015-03-20,Jim Cramer's Top Takeaways: Esperion Therapeutics, Platform Specialty Products
2015-03-19,Jim Cramer's 'Mad Money' Recap: The Markets Are Getting It All Wrong
2015-03-19,Esperion (ESPR) Stock Hits Another 52-Week High Today
2015-03-19,Jim Cramer's Top Takeaways: Starbucks, Magellan Mainstream, Regeneron
2015-03-18,Jim Cramer's 'Mad Money' Recap: The Fed Does the Right Thing
2015-03-18,Esperion (ESPR) Stock Hits 52-Week High on Analyst Upgrade - Jim Cramer Asks Where Profit-Takers Are
2015-03-17,Jim Cramer's 'Mad Money' Recap: This Maddening Market Can't Make Up Its Mind
2015-03-17,Cramer: Buy Bank of America, Citigroup if There's a Bounce in Stocks
2015-03-17,Esperion CEO Twitter Trolls His Larger, Cholesterol-Lowering Rivals
2015-03-10,'Mad Money' Lightning Round: Buy, Buy, Buy Spirit Airlines
2015-03-09,Jim Cramer's 'Mad Money' Recap: 6 Years of Market Gains, 10 Years of 'Mad Money'
2015-03-06,4 Big-Volume Stocks to Trade for Breakouts: Big Lots, Fresh Market and More
2015-02-03,Esperion Seen As Target After FDA Removes Hold On Cholesterol Drug Trial
2015-01-20,Eyes on the ECB
2015-01-16,Interesting ESPR Put And Call Options For February 20th
2015-01-15,Jim Cramer's Top Stock Picks: MNST ESPR CRL
2015-01-14,Jim Cramer's 'Mad Money' Recap: Will You Still Hate the Markets Tomorrow?
2015-01-06,Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains
2015-01-05,Esperion Therapeutics To Present At 33rd Annual J.P. Morgan Healthcare Conference
2014-11-25,Commit To Buy Esperion Therapeutics At $25, Earn 26% Annualized Using Options
2014-11-12,Esperion Therapeutics To Present At Stifel 2014 Healthcare Conference
2014-11-11,Esperion Therapeutics To Host And Webcast Live Investor Event
2014-11-10,Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2014 Financial Results
2014-11-05,Esperion Therapeutics To Present At Credit Suisse Healthcare Conference
2014-11-03,Esperion Therapeutics To Provide Third Quarter 2014 Results
2014-10-21,Esperion Therapeutics Announces Closing Of Follow-On Public Offering And Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock
2014-10-15,Esperion Therapeutics Prices Public Offering Of Common Stock
2014-10-14,Esperion Therapeutics Announces Proposed Public Offering Of Common Stock
2014-10-07,It's True, Small-Cap Biotech Stocks Are Acting Badly These Days
2014-10-01,Why Esperion Therapeutics (ESPR) Stock Is Soaring in After-Hours Trading Today
2014-10-01,Esperion Therapeutics Announces Positive Top-Line Phase 2b Results For ETC-1002, An Investigational Therapy For Patients With Hypercholesterolemia
2014-09-22,Esperion Therapeutics To Present At BioCentury’s NewsMakers In The Biotech Industry Conference
2014-08-12,Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2014 Financial Results
2014-08-05,Esperion Therapeutics To Provide Second Quarter 2014 Results
2014-08-04,4 Stocks Rising on Unusual Volume
2014-07-31,3 Biotech Stocks Breaking Out on Big Volume
2014-07-24,Esperion Therapeutics Announces Initiation Of A Phase 2 Clinical Study Of ETC-1002 In Patients With Hypercholesterolemia And Hypertension
2014-07-16,Esperion Therapeutics To Host Inaugural Analyst And Investor Day
2014-06-26,Esperion Therapeutics Announces The Appointment Of Gilbert S. Omenn, M.D., Ph.D. To Board Of Directors
2014-06-17,Esperion Therapeutics To Present At JMP Securities Healthcare Conference
2014-05-29,Esperion Therapeutics To Present At Jefferies 2014 Global Healthcare Conference
2014-05-12,Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports First Quarter 2014 Financial Results
2014-05-06,Esperion Therapeutics To Present At Bank Of America Merrill Lynch Healthcare Conference
2014-05-05,Esperion Therapeutics To Provide First Quarter 2014 Financial Results
2014-05-01,Esperion Therapeutics To Deliver Three Scientific Poster Presentations At The 2014 Annual Scientific Sessions Of The National Lipid Association
2014-03-24,Esperion Therapeutics To Present At BioCentury Future Leaders In The Biotech Industry Conference
2014-03-05,Esperion Therapeutics Provides ETC-1002 Program Update; Reports Fourth Quarter And Full Year 2013 Financial Results
2014-02-26,Esperion Therapeutics To Provide ETC-1002 Program Update; Fourth Quarter And Full Year 2013 Financial Results
2014-02-13,Esperion Therapeutics Names Mark E. McGovern, M.D., FACC, FACP, Director
2014-01-13,Esperion Therapeutics Announces The Appointment Of Antonio M. Gotto Jr., M.D., DPhil, As Director
2013-12-23,Esperion Therapeutics Added To The NASDAQ Biotechnology Index
2013-12-04,Relative Strength Alert For Esperion Therapeutics
2013-11-18,Esperion Therapeutics Presents Full Results Of Phase 2 Clinical Study Demonstrating That ETC-1002 Lowered LDL-C By An Average Of 32 Percent And Was Well Tolerated In Patients With Hypercholesterolemia And History Of Statin Intolerance
2013-11-11,Esperion Therapeutics Announces Oral Presentation On ETC-1002 At 2013 Scientific Sessions Of The American Heart Association
2013-11-06,Esperion Therapeutics Reports Third Quarter 2013 Financial Results And Provides Development Program Updates
2013-11-05,Esperion Therapeutics To Present At Credit Suisse Healthcare Conference
2013-10-30,Esperion Therapeutics Announces Initiation Of Phase 2b Clinical Study Of ETC-1002 In Patients With Or Without Statin Intolerance And Hypercholesterolemia
2013-09-24,Esperion Therapeutics To Present At BioCentury Newsmakers In The Biotech Industry Conference
2013-09-10,Esperion Therapeutics To Present At Stifel Nicolaus 2013 Healthcare Conference
2013-09-03,Esperion Therapeutics Announces Positive Top-Line Results From Phase 2 Clinical Study Of ETC-1002 As An Add-On To Statin Therapy In Patients With Hypercholesterolemia
2013-08-30,Esperion Therapeutics To Host Conference Call On September 3, 2013 To Announce Top-line Results From A Phase 2 Clinical Study Of ETC-1002 As An Add-On To Statin Therapy In Patients With Hypercholesterolemia
2013-08-12,Esperion Therapeutics Reports Second Quarter Financial Results And Provides Corporate Update
2013-07-11,Esperion Therapeutics, Inc. Announces Exercise Of Underwriters&#8217; Over-Allotment Option For Initial Public Offering
2013-06-26,NanoString Best BioTech IPO
2004-08-11,Fund Manager Sacane Sued by Short Over Wacky Stock Trades
2004-01-08,Another Company Settles With Sacane's Durus
2003-12-28,Weekend Reading: Not Your Typical Review
2003-12-23,Biotechs Benefit From Big Pharma's Buying Mood
2003-12-22,Terror Warning, Tremors Can't Derail the Dow
2003-12-22,Durus: How to Succeed in Stocks Without Really Trying
2003-12-22,Esperion Buyout Could Be Windfall for Sacane's Durus
2003-11-05,Stocks Close Mostly Lower
2003-11-04,Early Data Peek Puts Esperion Shares in a Jam
2003-11-04,Early Data Peek Puts Esperion Shares in a Jam
2003-10-27,Durus to Settle With Allos
2003-10-07,Now Novoste Sues Durus
2003-10-01,Durus Bails Out of Various Medical Holdings
2003-09-30,Appearance Is Everything at Quarter's End
2003-09-09,Screw Turning on Sacane at Durus Capital
2003-08-25,Another Company Sues Sacane, Durus
